Downregulation of PART1 Inhibits Proliferation and Differentiation of Hep3B Cells by Targeting hsa-miR-3529-3p/FOXC2 Axis

Figure 3

Effects of miR-3529-3p on hepatoma cells. (a) The expression level of miR-3529-3p; (b) the expression level of FOXC2; (c) the cell viability of Hep3B cells was analyzed by CCK-8 analysis and the clone formation; (d) the transwell invasion assays of Hep3B cells transfected with the miR-3529-3p mimic and the miR-3529-3p inhibitor; (e) FOXC2, MMP-2, and MMP-9 protein expression in Hep3B cells. All protein samples were isolated in Hep3B cells after transfection with miR-3529-3p mimic and the miR-3529-3p inhibitor. All of the data are expressed as the mean ± SD. Compared with control group, , , .

(a)

(b)

(c)

(d)

(e)